South San Francisco, California, United States · On-site
$25/hr–$30/hr
Senior$229M raised
Company Description Headquartered in San Francisco, CA, Cytovale is a dynamic, late-stage startup focused on developing a faster, more insightful way to diagnose fast-moving and immune-mediated diseases. Cytovale’s Intel…
Skills: Shipping, Receiving, Material Handling, Inventory Management, ERP Systems
About the Company: Cytovale is a leading innovator in early sepsis detection, revolutionizing emergency care with its advanced IntelliSep technology. This system provides rapid, actionable insights into a patient's likel…
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
$25/hr–$30/hr
Contract
Posted 4d ago
Apply by Sep 23
~40 hrs/week
Responsibilities
The role manages shipping, receiving, and general material handling activities to support product development and field service. Key tasks include performing ERP transactions, conducting monthly cycle counts, and ensuring orderly inventory storage.
Requirements
Candidates must have five or more years of experience in material handling and computer-based transactions, specifically with ERP systems. Physical ability to occasionally lift up to 80 pounds is required.
Full job description
Company Description Headquartered in San Francisco, CA, Cytovale is a dynamic, late-stage startup focused on developing a faster, more insightful way to diagnose fast-moving and immune-mediated diseases. Cytovale’s IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis. The test simply and clearly determines risk of sepsis using a biomechanical evaluation of white blood cells collected from a standard blood draw, generating results in under 10 minutes. This gives physicians actionable information when they need it most, allowing them to confidently triage suspected sepsis patients quickly and spend more time with those in greatest need. It also helps strained health systems prevent unnecessary treatment, preserve valuable resources, and improve compliance with SEP-1 guidelines.
The Material Handler / Warehouse Specialistreports to the Director of Supply Chain and provides material handling services across the organization. Responsibilities for this new position are broad in scope spanning Shipping, Receiving, and general material handling activities associated with processing inventory & supplies for product development, off-site manufacturing, field service engineers, and final customers. There is no traditional manufacturing at this site; this role primarily supports product development, and field service activities. Successful candidates comply with SOPs, demonstrate attention to detail, and accurately complete electronic transactions as well as paper-based records. This role is based in South San Francisco and requires in-office presence 5 days per week Monday through Friday.
Responsibilities
Receiving – Verify packing slip and material certification accuracy; Generate proper labeling, if necessary, perform relevant transactions in ERP
Deliver items to appropriate internal locations/owners
Shipping - Prepare packages and packing slips; Stage materials and/or hand off to logistics providers
Prepare required records and perform electronic transactions in Infor Syteline ERP
Performs monthly cycle counts of onsite materials
Performs material transfers and part issuing in ERP
Ensure orderly inventory storage, and compliance with Material Control procedures
Monitor certain supply levels; Reorder and/or restock as necessary
Qualifications:Five (5) or more years of experience performing similar material handling and computer-based transactions. Must be able to occasionally lift up to 80 pounds. Experience with ERP systems is required, with preference for experience with Infor Syteline.
Working Conditions:
Temperature controlled office environment
Who you are
Fast-learner with a “can-do” attitude and an ability to work independently
Desire to work in a high velocity startup where collaboration is prized
At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases.
Industry
Biotechnology Research
Company size
51-200 employees
Founded
2013
Headquarters
South San Francisco, California
LinkedIn followers
15,902
Total funding
$229M
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes.
Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential.
Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful.
Follow us on Twitter: twitter.com/cytovale
Offices: 2 Tower Pl, 18th Floor, South San Francisco, California 94080, US
medical deviceHealth DiagnosticsArtificial IntelligenceLife ScienceArtificial Intelligence (AI)Machine Learning
At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases.
Industry
Biotechnology Research
Company size
51-200 employees
Founded
2013
Headquarters
South San Francisco, California
LinkedIn followers
15,902
Total funding
$229M
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes.
Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential.
Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful.
Follow us on Twitter: twitter.com/cytovale
Offices: 2 Tower Pl, 18th Floor, South San Francisco, California 94080, US
medical deviceHealth DiagnosticsArtificial IntelligenceLife ScienceArtificial Intelligence (AI)Machine Learning